Netherlands

This scientific article was one of the 2018 EMCDDA scientific award winners, which celebrates scientific writing and distinguishes high-quality research in the field of illicit drugs. This article won the award in...

In the context of its contribution to monitoring HCV elimination among PWID in Europe, the EMCDDA conducted a study on current HCV policies, assessing if and how these refer to people who...

The national hepatitis plan “screening and beyond” officially launched in November 2016 was developed by a multidisciplinary commission representing all relevant stakeholders involved in research, treatment, prevention and control of hepatitis B...

This document presents an appendix to the 3 November 2015 letter to parliament about policy vision on drug prevention in the Netherlands.

This document presents the 3 November 2015 letter to parliament about policy vision on drug prevention in the Netherlands.

This document presents the Dutch drug policy letter of 27 May 2011.

This document presents the 2001 Dutch drug strategy 'A combined effort to combat ecstasy in the Netherlands'.

This document presents an English language version of the 1995 Dutch drug policy - continuity and change.

This document presents the Dutch language version of the 1995 Dutch drug policy - continuity and change.

This evaluation looks at the extent to which the main objective of Dutch drug policy has been achieved. This objective, as formulated in the 1995 Drug Report, concerns the prevention and control...